To use or not to use: an update on licit and illicit ketamine use

References

• McKetinRKozelNDouglasJThe rise of methamphetamine in Southeast and East AsiaDrug Alcohol Rev200827322022818368602
   PubMed Web of Science ®Google Scholar
• NavaratnamVWongPLReport of the Asian Multicity Epidemiology Workgroup 2002International Monograph Series No. 16Penang, MalaysiaCentre for Drug Research, Universiti Sains Malaysia2003
   Google Scholar
• DegenhardtLCopelandJDillonPRecent trends in the use of “club drugs”: an Australian reviewSubst Use Misuse2005409–101241125616048815
   PubMed Web of Science ®Google Scholar
• LianZLiuZLiuREpidemiological survey of ketamine in ChinaChin J Drug Depend2005144280283
   Google Scholar
• LiJHLiuSFYuWJPatterns and trends of drug abuse in Taiwan: a brief history and report from 2000 through 2004Epidemiologic trends in drug abuse, Vol II, Proceedings of the Community Epidemiology Work Group2005 JuneDenver, COBethesda, MDNIDA, NIH, DHHS2006
   Google Scholar
• CheungYWCheungNWTDrug policy in Hong Kong: changes and challengesAnti-Drug International Conference2010 June 2–3Taipei, Taiwan
   Google Scholar
• NoorzuraniRVicknasingamBNarayananSIllicit ketamine induced frequency of micturition in a young Malay womanDrug Alcohol Rev201029333433620565527
   PubMed Web of Science ®Google Scholar
• LiuCLiJHTsayWIHsuJDrug use and profile of individuals arrested on drug-related charges in TaiwanJ Food Drug Anal200513238
   Web of Science ®Google Scholar
• LeungKSLiJHTsayWIDinosaur girls, candy girls, and Trinity: voices of Taiwanese club drug usersJ Ethn Subst Abuse20087323725719042808
   PubMedGoogle Scholar
• DominoEFChodoffPCorssenGPharmacologic effects of CI-581, a new dissociative anesthetic in manClin Pharmacol Ther1965627929114296024
   PubMed Web of Science ®Google Scholar
• BergmanASKetamine: review of its pharmacology and its use in pediatric anesthesiaAnesth Prog1999461102010551055
   PubMedGoogle Scholar
• HansenGJensenSBChandreshLHildenTThe psychotropic effect of ketamineJ Psychoactive Drugs19882044194253244062
   PubMed Web of Science ®Google Scholar
• PalHRBerryNKumarRRayRKetamine dependenceAnaesth Intensive Care200230338238412075653
   PubMed Web of Science ®Google Scholar
• WolffKWinstockARKetamine from medicine to misuseCNS Drugs200620319921816529526
   PubMed Web of Science ®Google Scholar
• HarrisonNLSimmondsMAQuantitative studies on some antagonists of N-methyl D-aspartate in slices of rat cerebral cortexBr J Pharmacol19858423813912858237
   PubMed Web of Science ®Google Scholar
• WalkerAKIntramuscular ketamine in a developing country. Experience in the British Solomon IslandsAnaesthesia19722744084144634748
   PubMed Web of Science ®Google Scholar
• LankenauSEClattsMCDrug injection practices among high-risk youths: The first shot of ketamineJ Urban Health200481223224815136657
   PubMed Web of Science ®Google Scholar
• ReierCKetamine -“dissociative agent” or hallucinogen?N Engl J Med1971284147917925548039
   PubMed Web of Science ®Google Scholar
• SiegelRKPhencyclidine and ketamine intoxication: a study of four populations of recreational usersNIDA Res Monogr197821119147101865
   PubMedGoogle Scholar
• BrauMESanderFVogelWHempelmannGBlocking mechanisms of ketamine and its enantiomers in enzymatically demyelinated peripheral nerve as revealed by single-channel experimentsAnesthesiology19978623944049054257
   PubMed Web of Science ®Google Scholar
• DuqueJCOleskoviczNGuirroECValadaoCASoaresVERelative potency of ketamine and S(+)-ketamine in dogsJ Vet Pharmacol Ther200831434434818638295
   PubMed Web of Science ®Google Scholar
• KrystalHKarperLPSeibylJPSubanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responsesArch Gen Psychiatry19945131992148122957
   PubMed Web of Science ®Google Scholar
• NewcomerJWFarberNBJevtovic-TodorovicVKetamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosisNeuropsychopharmacology19992021061189885791
   PubMed Web of Science ®Google Scholar
• HirotaKOkawaHAppaduBLGrandyDKDeviLALambertDGSterioselective interaction of ketamine with recombinant mu, kappa and delta opioid receptors expressed in Chinese hamster ovary cellsAnesthesiology19999011741829915326
   PubMed Web of Science ®Google Scholar
• NishimuraNSatoKOkadaTKetamine inhibits monoamine transporters expressed in human embryonic kidney 293 cellsAnesthesiology19988837687749523822
   PubMed Web of Science ®Google Scholar
• CurranHVMorganCCognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days laterAddiction200095457559010829333
   PubMed Web of Science ®Google Scholar
• WeinerALVieiraLMcKayCABayerMJKetamine abusers presenting to the emergency department: a case seriesJ Emerg Med200018444745110802423
   PubMed Web of Science ®Google Scholar
• KoobGFAnatomy, pharmacology and function of reward pathwaysTrends Pharmacol Sci19921351771851604710
   PubMed Web of Science ®Google Scholar
• WhitePFWayWLTrevorAJKetamine: its pharmacology and therapeutic usesAnaesthesiology1982562119136
   Web of Science ®Google Scholar
• WalkerSMGoudasLCCousinsMJCarrDBCombination spinal analgesic chemotherapy: a systematic reviewAnesth Analg200295367471512198058
   PubMed Web of Science ®Google Scholar
• HockingGCousinsMJKetamine in chronic pain management: an evidence-based reviewAnesth Analg20039761730173914633551
   PubMed Web of Science ®Google Scholar
• ZeilhoferHUSwandullaDGeisslingerGBruneKDifferential effects of ketamine enantiomers on NMDA receptor currents in cultured neuronsEur J Pharmacol199221311551581386806
   PubMed Web of Science ®Google Scholar
• ReichDLSilvayGKetamine: an update on the first twenty-five years of clinical experienceCan J Anaesth19893621861972650898
   PubMed Web of Science ®Google Scholar
• VollenweiderFXLeendersKLOyeIHellDAngstJDifferential psychopathology and patterns of cerebral glucose utilization produced by (S)- and (R) -ketamine in healthy volunteers using positron emission tomography (PET)Eur Neuropsychopharmacol19977125389088882
   PubMed Web of Science ®Google Scholar
• PabelickCMRehderKJonesKAShumwayRLindahlSGWarnerDOStereospecific effects of ketamine enantiomers on canine tracheal smooth muscleBr J Pharmacol19971217137813829257917
   PubMed Web of Science ®Google Scholar
• LankveldDPDriessenBSomaLRPharmacodynamic effects and pharmacokinetic profile of a long-term continuous rate infusion of racemic ketamine in healthy conscious horsesJ Vet Pharmacol Ther200629647748817083451
   PubMed Web of Science ®Google Scholar
• ChengPSFuCYLeeCHLiuCChienCSGC-MS quantification of ketamine, norketamine, and dehydronorketamine in urine specimens and comparative study using ELISA as the preliminary test methodologyJ Chromatogr B Analyt Technol Biomed Life Sci20078521–2443449
   Web of Science ®Google Scholar
• YanagiharaYKariyaSOhtaniMInvolvement of CYP2B6 in n-demethylation of ketamine in human liver microsomesDrug Metab Dispos200129688789011353758
   PubMed Web of Science ®Google Scholar
• HijaziYBoulieuRContribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomesDrug Metab Dispos200230785385812065445
   PubMed Web of Science ®Google Scholar
• LoJNCummingJFInteraction between sedative premedicants and ketamine in man in isolated perfused rat liversAnesthesiology19754333073121163830
   PubMed Web of Science ®Google Scholar
• WhitePFVasconezLOMathesSAWayWLWenderLAComparison of midazolam and diazepam for sedation during plastic surgeryPlast Reconstr Surg19888157037123283789
   PubMed Web of Science ®Google Scholar
• SkolnickPPopikPTrullasRGlutamate-based antidepressants: 20 years onTrends Pharmacol Sci2009301156356919837463
   PubMed Web of Science ®Google Scholar
• DiazgranadosNIbrahimLBrutscheNEA randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depressionArch Gen Psychiatry201067879380220679587
   PubMed Web of Science ®Google Scholar
• ZhaoYSunLAntidepressants modulate the in vitro inhibitory effects of propofol and ketamine on norepinephrine and serotonin transporter functionJ Clin Neurosci200815111264126918815045
   PubMed Web of Science ®Google Scholar
• LiNLeeBLiuRJmTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonistsScience2010329599495996420724638
   PubMed Web of Science ®Google Scholar
• VollenweiderFXKometerMThe neurobiology of psychedelic drugs: implications for the treatment of mood disordersNat Rev Neurosci201011964265120717121
   PubMed Web of Science ®Google Scholar
• HashimotoKEmerging role of glutamate in the pathophysiology of major depressive disorderBrain Res Review2009612105123
   PubMed Web of Science ®Google Scholar
• BelmakerRHAgamGMajor depressive disorderN Engl J Med20083581556818172175
   PubMed Web of Science ®Google Scholar
• JavittDCGlutamate as a therapeutic target in psychiatric disordersMol Psychiatry200491198499715278097
   PubMed Web of Science ®Google Scholar
• GoffDCHillMBarchDThe treatment of cognitive impairment in schizophreniaPharmacol Biochem Behav20101127 [Epub ahead of print]10.1016/j.pbb.2010.11.009
   Web of Science ®Google Scholar
• DavisKKahnRKoGDavidsonMDopamine in schizophrenia: a review and reconceptualizationAm J Psychiatry19911481119071917
   Web of Science ®Google Scholar
• CurranCByrappaNMcBrideAStimulant psychosis: systematic reviewBr J Psychiatry200418519620415339823
   PubMed Web of Science ®Google Scholar
• JavittDCZukinSRRecent advances in the phencyclidine model of schizophreniaAm J Psychiatry199114810130113081654746
   PubMed Web of Science ®Google Scholar
• DuncanEJMadonickSHParwaniAClinical and sensorimotor gating effects of ketamine in normalsNeuropsychopharmacology2001251728311377920
   PubMed Web of Science ®Google Scholar
• MalhotraAKPinalsDAAdlerCMKetamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenicsNeuropsychopharmacology19971731411509272481
   PubMed Web of Science ®Google Scholar
• NaritaMYoshizawaKAokiKTakagiMMiyatakeMSuzukiTA putative sigma1 receptor antagonist NE-100 attenuates the discriminative stimulus effects of ketamine in ratsAddict Biol20016437337611900615
   PubMed Web of Science ®Google Scholar
• KrupitskyEMGrinenkoAYKetamine psychedelic therapy (KPT): a review of the results of ten years of researchJ Psychoactive Drugs19972921651839250944
   PubMed Web of Science ®Google Scholar
• KrupitskyEMBurakovAMDunaevskyIVRomanovaTNSlavinaTYGrinenkoAYSingle versus repeated sessions of ketamine-assisted psychotherapy for people with heroin dependenceJ Psychoactive Drugs2007391131917523581
   PubMed Web of Science ®Google Scholar
• GreenSMLiJKetamine in adults: what emergency physicians need to know about patient selection and emergence reactionsAcad Emerg Med20007327828110730837
   PubMed Web of Science ®Google Scholar
• MoghaddamBAdamsBVermaADalyDActivation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortexJ Neurosci1997178292129279092613
   PubMed Web of Science ®Google Scholar
• ChenRLeeAMChanRA study on the cognitive impairment and other harmful effects from ectasy and ketamine abuseHong Kong Chinese 2004Hong KongNarcotics Division, Security Bureau, Government of the Hong Kong Special Administrative Region2004
   Google Scholar
• LimDKKetamine associated psychedelic effects and dependenceSingapore Med J2003441313412762561
   PubMedGoogle Scholar
• PenningRVeldstraJLDaamenAPOlivierBVersterJCDrugs of abuse, driving and traffic safetyCurr Drug Abuse Rev201031233220088818
   PubMedGoogle Scholar
• MorganCJMofeezABrandnerBBromleyLCurranHVKetamine impairs response inhibition and is positively reinforcing in healthy volunteers: a dose–response studyPsychopharmacology2004172329830814727004
   PubMed Web of Science ®Google Scholar
• MorganCJMuetzelfeldtLCurranHVKetamine use, cognition and psychological wellbeing: a comparison of frequent, infrequent and ex-users with polydrug and non-using controlsAddiction20091041778719133891
   PubMed Web of Science ®Google Scholar
• MorganCJMuetzelfeldtLCurranHVConsequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal studyAddiction201010512113319919593
   PubMed Web of Science ®Google Scholar
• MorganCJMonaghanLCurranHVBeyond the K-hole: a 3-year longitudinal investigation of the cognitive and subjective effects of ketamine in recreational users who have substantially reduced their use of the drugAddiction200499111450146115500598
   PubMed Web of Science ®Google Scholar
• LiaoYTangJCorlettPRReduced dorsal prefrontal gray matter after chronic ketamine useBiol Psychiatry2011691424821035788
   PubMed Web of Science ®Google Scholar
• LiaoYTangJMaMFrontal white matter abnormalities following chronic ketamine use: a diffusion tensor imaging studyBrain2010133Pt 72115212220519326
   PubMed Web of Science ®Google Scholar
• StorrTMQuibellRCan ketamine prescribed for pain cause damage to the urinary tract?Palliat Med200923767067219648225
   PubMed Web of Science ®Google Scholar
• TsaiTHChaTLLinCMKetamine-associated bladder dysfunctionInt J Urol2009161082682919659678
   PubMed Web of Science ®Google Scholar
• MasonKCottrellAMCorriganAGGillattDAMitchelmoreAEKetamine-associated lower urinary tract destruction: a new radiological challengeClin Radiol2010651079580020797465
   PubMed Web of Science ®Google Scholar
• ChuPSMaWKWongSCThe destruction of the lower urinary tract by ketamine abuse: a new syndrome?BJU Int2008102111616162218680495
   PubMed Web of Science ®Google Scholar
• ToyamaYShimizuHSuzukiYMiyakoshiYYoshiokaHGenotoxic effects of N-nitrosoketamine and ketamine as assessed by in vitro micronucleus test in Chinese hamster lung fibroblast cell lineEnviron Health Prev Med200611312012721432386
   PubMedGoogle Scholar
• LiJHLinLFGenetic toxicology of abused drugs: a brief reviewMutagenes1998136557565
   PubMed Web of Science ®Google Scholar
• WoodworthTDEA congressional testimony before the House Commerce Committee subcommittee on oversight and investigations3111999 Available from: http://www.justice.gov/dea/pubs/cngrtest/ct990311.htmAccessed February 9, 2011
   Google Scholar
• NegruszAGaensslenREAnalytical developments in toxicological investigation of drug-facilitated sexual assaultAnal Bioanal Chem200337681192119712682705
   PubMed Web of Science ®Google Scholar
• AnglinDSpearsKLHutsonHRFlunitrazepam and its involvement in date or acquaintance rapeJ Accid Emerg Med199744323326
   Google Scholar
• DAWNEmergency department trends from the Drug Abuse Warning Network DAWN: final estimates 1995–2002 DHHS Publication no. (SMA) 03-3780Rockville, MDDepartment of Health and Human Services2003
   Google Scholar
• FoxJWhitePJMacdonaldNReductions in HIV transmission risk behavior following diagnosis of primary HIV infection: a cohort of high-risk men who have sex with menHIV Med200910743243819459996
   PubMed Web of Science ®Google Scholar
• ParkerHAldridgeJMeashamFIllegal Leisure: The normalization of adolescent recreational drug useLondon, UKRoutledge1998
   Google Scholar
• National Narcotic Board (BNN)Survey on Drug Use among Workers and StudentsJakarta, IndonesiaNational Narcotic Board2009
   Google Scholar
• Royal Malaysian PoliceNarcotics Investigation Department Statistical BookKuala Lumpur, MalaysiaRoyal Malaysian Police2010
   Google Scholar
• LiJHLiangKYWuSiJoint Report of National Household Survey on Health and Substance Abuse 2005. National Bureau of Controlled Drugs, National Bureau of Health Promotion, National Health Research InstitutesReport of National Household Survey on Health and Substance Abuse 2005Taipei, TaiwanDepartment of Health2006
   Google Scholar
• ChenWJFuTCTingTTUse of ecstasy and other psychoactive substances among school-attending adolescents in Taiwan: national surveys 2004–2006BMC Public Health200992719159468
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration, Department of Health, Executive YuanStatistics of drug abuse in Taiwan [Updated 2011 Feb 20] Available from: http://www.fda.gov.tw/fles/site_contentAccessed February 24, 2011
   Google Scholar
• NuttDKingLASaulsburyWBlakemoreCDevelopment of a rational scale to assess the harm of drugs of potential misuseLancet200736995661047105317382831
   PubMed Web of Science ®Google Scholar
• RicaurteGAMcCannRecognition and management of complications of new recreational drug useLancet200536594772137214515964451
   PubMed Web of Science ®Google Scholar
• Van AmsterdamJGBestWOpperhuizenAde WolffFAEvaluation of a procedure to assess the adverse effects of illicit drugsRegul Toxicol Pharmacol20043911414746774
   PubMed Web of Science ®Google Scholar
• HenningfieldJESchusterCRRisk management and post-marketing surveillance of CNS drugsDrug and Alcohol Depend2009105Suppl 1S56S64
   PubMed Web of Science ®Google Scholar
• PortmannSKwanHYTheurillatRSchnitzAMevissenMThormannWEnantioselective capillary electrophoresis for identification and characterization of human cytochrome P450 enzymes which metabolize ketamine and norketamine in vitroJ Chromatogr A20101217517942794820609441
   PubMed Web of Science ®Google Scholar
• HijaziYBoulieuRContribution of CYP3 A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomesDrug Metab Dispos200230785385812065445
   PubMed Web of Science ®Google Scholar